Attention Deficit Hyperactivity Disorder (ADHD) Market Analysis Report By Drug Type (Stimulant, Non-stimulant), By Demographic, By Distribution Channel (Hospital & Retail Pharmacy), And Segment Forecasts, 2019 - 2025

Published: Feb, 2019 | Pages: 100 | Publisher: Grand View Research
Industry: Pharmaceutical | Report Format: Electronic (PDF)

The global attention deficit hyperactivity disorder market size is expected to reach USD 24.9 billion by 2025, based on a new report by Grand View Research, Inc., exhibiting a 6.4% CAGR during the forecast period. Increase in awareness regarding ADHD among patients, physicians, and other healthcare providers is likely to up demand for effective treatment, in turn, propelling market growth.

Furthermore, there has been a steady rise in ADHD patients during the last 20 years. According to a study conducted by the National Health Interview Survey, the prevalence of ADHD among children and adolescents in U.S. rose from 6.1% in 1997-1998 to 10.2% in 2015-2016.

Approval and commercialization of drugs, increase in number of clinical trials, and rise in awareness regarding diagnosis and treatment of the condition is expected to boost market growth over the forecast period.

Further key findings from the study suggest:

• Increasing access to health insurance for mental health treatment and rising incidence of ADHD are expected to propel market growth in the coming years

• By drug type, the stimulant drugs segment accounted for the largest share in the market in 2018 and is anticipated to maintain its dominance during the forecast period. This can be attributed to effectiveness of drugs in treating of ADHD symptoms and commercialization of new drugs

• Based on demographics, adults held the maximum share in the ADHD market in 2018 due to high prevalence of the condition across the globe, increased awareness about mental health, and launch of effective drugs with minimum adverse effects

• By distribution channel, retail pharmacy accounted for the largest share in 2018 due to increasing number of prescriptions. This can be attributed to rise in patient care initiatives by retail pharmacies

• Geographically, North America dominated the global ADHD market in 2018 owing to high awareness of mental health, increasing patient population, and local presence of market players

• Asia Pacific is anticipated to observe significant growth during the forecast period owing to government initiatives to provide effective treatment for ADHD and rising patient population due to stressful lifestyle

• Some of the key players in the market are Eli Lily & Company; Pfizer; Johnson & Johnson Services, LLC; Lupin; Shire; Mallinckrodt; Prude Pharma L.P.; and NEOS Therapeutics Inc.

 Table of Contents

Chapter 1 Executive Summary
                   1.1 Market Snapshot

Chapter 2 Market Definitions
                   2.1 Objective

Chapter 3 Research Methodology
                   3.1 Information Procurement
                   3.2 Data Analysis

Chapter 4 Market Variables, Trends, & Scope
                   4.1 Market Segmentation and Scope
                       4.1.1 Market driver analysis
                           4.1.1.1 Increasing prevalence of ADHD
                           4.1.1.2 Increasing awareness regarding ADHD among physicians and patients
                       4.1.2 Market restraint analysis
                           4.1.2.1 Less availability of non-stimulants ADHD drugs
                           4.1.2.2 Underdiagnosis of ADHD
                   4.2 Penetration & Growth Prospects Mapping
                   4.3 Attention deficit hyperactivity disorder (ADHD) Market - PESTLE Analysis
                   4.4 Industry Analysis - Porter's
                   4.5 Attention deficit hyperactivity disorder (ADHD) Competitive Landscape: Market Position Analysis (Based on Services, Regional Presence, and Recent Updates)

Chapter 5 Attention Deficit Hyperactivity Disorder (ADHD) Market : Drug Estimates & Trend Analysis
                   5.1 Amphetamine
                       5.1.2 Amphetamines market, 2014 - 2025 (USD Million)
                   5.2 Methylphenidate
                       5.2.1 Methylphenidate market, 2014 - 2025 (USD Million)
                   5.3 Lisdexamfetamine
                       5.3.1 Lisdexamfetamine market, 2014 - 2025 (USD Million)
                   5.4 Dexmethylphenidate
                       5.4.1 Dexmethylphenidate market, 2014 - 2025 (USD Million)
                   5.5 Atomoxetine
                       5.5.1 Atomoxetine market, 2014 - 2025 (USD Million)
                   5.6 Guanfacine
                       5.6.1 Guanfacine market, 2014 - 2025 (USD Million)
                   5.7 Clonidine
                       5.7.1 Clonidine market, 2014 - 2025 (USD Million)
                   5.8 Bupropion
                       5.8.1 Bupropion market, 2014 - 2025 (USD Million)

Chapter 6 Attention Deficit Hyperactivity Disorder (ADHD) Market : Drug Type Estimates & Trend Analysis
                   6.1 Attention Deficit Hyperactivity Disorder (ADHD) Market: Drug Type Analysis
                   6.2 Stimulants
                       6.2.1. Stimulants market, 2014 - 2026 (USD Million)
                   6.3 Non-Stimulants
                       6.3.1 Non-stimulants market, 2014 - 2026 (USD Million)

Chapter 7 Attention Deficit Hyperactivity Disorder (ADHD) Market : Demographic Estimates & Trend Analysis
                   7.1 Attention Deficit Hyperactivity Disorder (ADHD) Market: By Age Analysis
                       7.1.1 Children (2-17 years of age)
                           7.1.1.1 Children (2-17 years of age) market, 2014 - 2025 (USD Million)
                       7.1.2 Adults
                           7.1.2.1 Adults market, 2014 - 2025 (USD Million)

Chapter 8 Attention Deficit Hyperactivity Disorder (ADHD) Market : Distribution Channel Estimates & Trend Analysis
                   8.1 Attention Deficit Hyperactivity Disorder (ADHD) Market: Distribution Channel Analysis
                   8.2 Hospital Pharmacy
                       8.2.1 Hospital Pharmacy market, 2014 - 2025 (USD Million)
                   8.3 Retail Pharmacy
                       8.3.1 Retail Pharmacy market, 2014 - 2025 (USD Million)

Chapter 9 Attention deficit hyperactivity disorder (ADHD) Market : Regional Estimates & Trend Analysis
                   9.1 Attention Deficit Hyperactivity Disorder (ADHD) Market Share, By Region, 2014 & 2025
                   9.2 North America
                       9.2.1 US
                           9.2.1.1 U.S. attention deficit hyperactivity disorder (ADHD) market, 2014 - 2025 (USD Million)
                       9.2.2 Canada
                           9.2.2.1 Canada attention deficit hyperactivity disorder (ADHD) market, 2014 - 2025 (USD million )
                   9.3 Europe
                       9.3.1 Europe attention deficit hyperactivity disorder (ADHD) market, 2014 - 2025 (USD Million)
                       9.3.2 U.K.
                           9.3.2.1 U.K. attention deficit hyperactivity disorder (ADHD) market, 2014 - 2025 (USD Million)
                       9.3.3 Germany
                           9.3.3.1 Germany attention deficit hyperactivity disorder (ADHD) market, 2014 - 2025 (USD Million)
                       9.3.4 France
                           9.3.4.1 Germany attention deficit hyperactivity disorder (ADHD) market, 2014 - 2025 (USD Million)
                   9.4 Asia Pacific
                       9.4.1 Asia Pacific attention deficit hyperactivity disorder (ADHD) market, 2014 - 2025 (USD Million)
                       9.4.2 Japan
                           9.4.2.1 Japan Attention deficit hyperactivity disorder (ADHD) Market, 2014 - 2025 (USD Million)
                       9.4.3 China
                           9.4.3.1 China attention deficit hyperactivity disorder (ADHD) market, 2014 - 2025 (USD Million)
                   9.5 Latin America
                       9.5.1 Latin America attention deficit hyperactivity disorder (ADHD) market, 2014 - 2025 (USD Million)
                       9.5.2 Brazil
                           9.5.2.1 Brazil attention deficit hyperactivity disorder (ADHD) market, 2014 - 2025 (USD Million)
                       9.5.3 Mexico
                           9.5.3.1 Mexico attention deficit hyperactivity disorder (ADHD) market, 2014 - 2025 (USD Million)
                   9.6 MEA
                       9.6.1 MEA attention deficit hyperactivity disorder (ADHD) market, 2014 - 2025 (USD Million)
                       9.6.2 South Africa
                           9.6.2.1 South Africa attention deficit hyperactivity disorder (ADHD) market, 2014 - 2025 (USD Million)

Chapter 10 Competitive Landscape
                   10.1 Strategy Framework
                   10.2 Company Profiles
                       10.2.1 Eli Lily & Company
                           10.2.1.1 Company overview
                           10.2.1.2 Financial performance
                           10.2.1.3 Product benchmarking
                           10.2.1.4 Strategic initiatives
                       10.2.2 Novartis AG
                           10.2.2.1 Company overview
                           10.2.2.2 Financial performance
                           10.2.2.3 Product benchmarking
                           10.2.2.4 Strategic initiatives
                       10.2.3 Pfizer
                           10.2.3.1 Company overview
                           10.2.3.2 Financial performance
                           10.2.3.3 Product benchmarking
                           10.2.3.4 Strategic initiatives
                       10.2.4 Johnson & Johnson Services, LLC
                           10.2.4.1 . Company overview
                           10.2.4.2 Financial performance
                           10.2.4.3 Product benchmarking
                           10.2.4.4 Strategic initiatives
                       10.2.5 Lupin
                           10.2.5.1 Company overview
                           10.2.5.1 Financial performance
                           10.2.5.2 Product benchmarking
                           10.2.5.3 Strategic initiatives
                       10.2.6 Shire
                           10.2.6.1 Company overview
                           10.2.6.2 Financial performance
                           10.2.6.3 Product benchmarking
                           10.2.6.4 Strategic initiatives
                       10.2.7 Mallinckrodt
                           10.2.7.1 Company overview
                           10.2.7.2 Financial performance
                           10.2.7.3 Product benchmarking
                           10.2.7.4 Strategic initiatives
                       10.2.8 Prude Pharma L.P.
                           10.2.8.1 Company overview
                           10.2.8.2 Financial performance
                           10.2.8.3 Product benchmarking
                           10.2.8.4 Strategic initiatives
                       10.2.9 NEOS Therapeutics Inc.
                           10.2.9.1 Company overview
                           10.2.9.2 Financial performance
                           10.2.9.3 Product benchmarking
                           10.2.9.4 Strategic initiatives

List of Tables

TABLE 1 FDA-Approved ADHD Medication
TABLE 2 Non-stimulants medications used for ADHD
TABLE 3 ADHD stimulants retail prices in the U.S., 2012
TABLE 4 North America ADHD market, by country, 2014 - 2025 (USD Million)
TABLE 5 North America ADHD, by drug type, 2014 - 2025 (USD Million)
TABLE 6 North America ADHD market, by demographics, 2014 - 2025 (USD Million)
TABLE 7 North America ADHD market, by distribution channel, 2014 - 2025 (USD Million)
TABLE 8 U.S. ADHD market, by drug type, 2014 - 2025 (USD Million)
TABLE 9 U.S. ADHD market, by demographics, 2014 - 2025 (USD Million)
TABLE 10 U.S. ADHD market, by distribution channel, 2014 - 2025 (USD Million)
TABLE 11 Canada ADHD market, by drug type, 2014 - 2025 (USD Million)
TABLE 12 Canada ADHD market, by demographics, 2014 - 2025 (USD Million)
TABLE 13 Canada ADHD market, by distribution channel, 2014 - 2025 (USD Million)
TABLE 14 Europe ADHD market, by country, 2014 - 2025 (USD Million)
TABLE 15 Europe ADHD market, by drug type, 2014 - 2025 (USD Million)
TABLE 16 Europe ADHD market, by demographics, 2014 - 2025 (USD Million)
TABLE 17 Europe ADHD market, bydistribution channel, 2014 - 2025 (USD Million)
TABLE 18 U.K. ADHD market, by drug type, 2014 - 2025 (USD Million)
TABLE 19 U.K. ADHD market, by demographics, 2014 - 2025 (USD Million)
TABLE 20 U.K. ADHD market, bydistribution channel, 2014 - 2025 (USD Million)
TABLE 21 Germany ADHD market, by drug type, 2014 - 2025 (USD Million)
TABLE 22 Germany ADHD market, by demographics, 2014 - 2025 (USD Million)
TABLE 23 Germany ADHD market, bydistribution channel, 2014 - 2025 (USD Million)
TABLE 24 France ADHD market, by drug type, 2014 - 2025 (USD Million)
TABLE 25 France ADHD market, by demographics, 2014 - 2025 (USD Million)
TABLE 26 France ADHD market, bydistribution channel, 2014 - 2025 (USD Million)
TABLE 27 Asia Pacific ADHD market, by country, 2014 - 2025 (USD Million)
TABLE 28 Asia Pacific ADHD market, by drug type, 2014 - 2025 (USD Million)
TABLE 29 Asia Pacific ADHD market, by demographics, 2014 - 2025 (USD Million)
TABLE 30 Asia Pacific ADHD market, bydistribution channel, 2014 - 2025 (USD Million)
TABLE 31 Japan ADHD market, by drug type, 2014 - 2025 (USD Million)
TABLE 32 Japan ADHD market, by demographics, 2014 - 2025 (USD Million)
TABLE 33 Japan ADHD market, bydistribution channel, 2014 - 2025 (USD Million)
TABLE 34 China ADHD market, by drug type, 2014 - 2025 (USD Million)
TABLE 35 China ADHD market, by demographics, 2014 - 2025 (USD Million)
TABLE 36 China ADHD market, bydistribution channel, 2014 - 2025 (USD Million)
TABLE 37 Latin America ADHD market, by country, 2014 - 2025 (USD Million)
TABLE 38 Latin America ADHD market, by drug type, 2014 - 2025 (USD Million)
TABLE 39 Latin America ADHD market, by demographics, 2014 - 2025 (USD Million)
TABLE 40 Latin America ADHD market, bydistribution channel, 2014 - 2025 (USD Million)
TABLE 41 Brazil ADHD market, by drug type, 2014 - 2025 (USD Million)
TABLE 42 Brazil ADHD market, by demographics, 2014 - 2025 (USD Million)
TABLE 43 Brazil ADHD market, bydistribution channel, 2014 - 2025 (USD Million)
TABLE 44 Mexico ADHD market, by drug type, 2014 - 2025 (USD Million)
TABLE 45 Mexico ADHD market, by demographics, 2014 - 2025 (USD Million)
TABLE 46 Mexico ADHD market, bydistribution channel, 2014 - 2025 (USD Million)
TABLE 47 MEA ADHD market, by country, 2014 - 2025 (USD Million)
TABLE 48 MEA ADHD market, by drug type, 2014 - 2025 (USD Million)
TABLE 49 MEA ADHD market, by demographics, 2014 - 2025 (USD Million)
TABLE 50 MEA ADHD market, bydistribution channel, 2014 - 2025 (USD Million)
TABLE 51 South Africa ADHD market, by drug type, 2014 - 2025 (USD Million)
TABLE 52 South Africa ADHD market, by demographics, 2014 - 2025 (USD Million)
TABLE 53 South Africa ADHD market, bydistribution channel, 2014 - 2025 (USD Million)

List of Figures

FIG. 1 Market summary 2018, (USD million)
FIG. 2 Market research process
FIG. 3 Information procurement
FIG. 4 Primary research pattern
FIG. 5 Market research approaches
FIG. 6 Value chain based sizing & forecasting
FIG. 7 QFD modelling for market share assessment
FIG. 8 Market trends & outlook
FIG. 9 Market segmentation & scope
FIG. 10 Market driver relevance analysis (Current & future impact)
FIG. 11 Market restraint relevance analysis (Current & future impact)
FIG. 12 Penetration & growth prospect mapping
FIG. 13 Attention deficit hyperactivity disorder (ADHD) market - PESTLE analysis
FIG. 14 Porter's five forces analysis
FIG. 15 Attention deficit hyperactivity disorder (ADHD) competitive landscape: Market position analysis (based on product portfolio, regional presence, and strategic initiatives)
FIG. 16 Amphetamines market, 2014 - 2025 (USD Million)
FIG. 17 Methylphenidate market, 2014 - 2025 (USD Million)
FIG. 18 Lisdexamfetamine market, 2014 - 2025 (USD Million)
FIG. 19 Dexmethylphenidate market, 2014- 2025 (USD Million)
FIG. 20 Atomoxetine market, 2014 - 2025 (USD Million)
FIG. 21 Guanfacine market, 2014 - 2025 (USD Million)
FIG. 22 Clonidine market, 2014 - 2025 (USD Million)
FIG. 23 Bupropion market, 2014 - 2025 (USD Million)
FIG. 24 Attention deficit hyperactivity disorder (ADHD) market, drug type outlook: Key takeaways
FIG. 25 Attention deficit hyperactivity disorder (ADHD) market: drug type movement analysis
FIG. 26 Stimulants market, 2014 - 2025 (USD Million)
FIG. 27 Non-stimulants market, 2014 - 2025 (USD Million)
FIG. 28 Attention deficit hyperactivity disorder (ADHD) market, Demographic outlook: Key takeaways
FIG. 29 Attention deficit hyperactivity disorder (ADHD) market: By demographic movement analysis
FIG. 30 Children (2-17 years of age) ADHD market, 2014 - 2025 (USD Million)
FIG. 31 Adults ADHD market, 2014 - 2025 (USD Million)
FIG. 32 Attention deficit hyperactivity disorder (ADHD) market, Distribution channel outlook: Key takeaways
FIG. 33 Attention deficit hyperactivity disorder (ADHD) market: Distribution channel movement analysis
FIG. 34 Hospital pharmacy market, 2014 - 2025 (USD Million)
FIG. 35 Retail pharmacy market, 2014 - 2025 (USD Million)
FIG. 36 Regional market place: Key takeaways
FIG. 37 Attention deficit hyperactivity disorder (ADHD) market: Regional outlook, 2014 & 2025
FIG. 38 North America ADHD market, 2014 - 2025 (USD Million)
FIG. 39 U.S. ADHD market, 2014 - 2025 (USD Million)
FIG. 40 Canada ADHD market, 2014 - 2025 (USD million )
FIG. 41 Europe ADHD market, 2014 - 2025 (USD Million)
FIG. 42 U.K. ADHD market, 2014 - 2025 (USD Million)
FIG. 43 Germany ADHD market, 2014 - 2025 (USD Million)
FIG. 44 France ADHD market, 2014 - 2025 (USD Million)
FIG. 45 Asia Pacific ADHD market, 2014 - 2025 (USD Million)
FIG. 46 Japan ADHD market, 2014 - 2025 (USD Million)
FIG. 47 China ADHD Market, 2014 - 2025 (USD Million)
FIG. 48 Latin America ADHD market, 2014 - 2025 (USD Million)
FIG. 49 Brazil ADHD market, 2014 - 2025 (USD Million)
FIG. 50 Mexico ADHD market, 2014 - 2025 (USD Million)
FIG. 51 MEA ADHD market, 2014 - 2025 (USD Million)
FIG. 52 South Africa ADHD market, 2014 - 2025 (USD Million)
FIG. 53 Strategy framework